Skip to content

Price / book at other companies

Moderna logo
ModernaMRNA
2.7×+1.6×
Roivant Sciences logo
Roivant SciencesROIV
4.4×+2.8×
Incyte logo
IncyteINCY
3.3×+0.1×
United Therapeutics logo
United TherapeuticsUTHR
4.4×+2.4×
Amgen logo
AmgenAMGN
20.6×-6.3×
Royalty Pharma logo
Royalty PharmaRPRX
2.1×+0.7×

Other financials

Income statement

See full
Revenue$1.2B+96.4%
Gross profit$959.7M+83.1%
Operating income$268.6M+1,386%
Net income$206.0M+1,229%
EPS (diluted)$1.51+1,179%

Balance sheet

See full
Cash & equivalents$1.7B+67.5%
Total debt$263.7M-4.5%
Total equity$1.1B+152%
Total assets$5.1B+21.7%

Cash flow

See full
Operating cash flow$70.5M+159%
CapEx$21.8M+143%
Free cash flow$48.7M+138%

Valuation

See full
Market cap$37.75B+25.6%
Enterprise value$36.3B+24.1%
P/E75.1×
P/S8.8×-4.0×

Profitability

See full
Gross margin81%-5.3pp
Operating margin17.5%+14.4pp
Net margin11.7%+8.0pp

Returns & leverage

See full
Return on equity66.9%
Debt / equity0.2×-0.4×
Current ratio3.1×+0.1×

Where this comes from

Calculated from Alnylam Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alnylam Pharmaceuticals's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alnylam Pharmaceuticals's price / book?
Alnylam Pharmaceuticals (ALNY) reported price / book of 40.8× in Q1 2026.
How has Alnylam Pharmaceuticals's price / book changed year-over-year?
Alnylam Pharmaceuticals's price / book decreased by 50.2% year-over-year, from 82× to 40.8×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.